Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat

Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat

- Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) regulatory pathway. - The company has received...

Lufax Receives NYSE Notice Regarding Late Filing of Annual Report on Form 20-F

Lufax Receives NYSE Notice Regarding Late Filing of Annual Report on Form 20-F

SHANGHAI, May 13, 2025 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that it received a notice from the New York Stock...

KLN's Progress in ESG Disclosure Recognised by the HKQAA Hong Kong Green and Sustainability Contribution Awards 2025

KLN's Progress in ESG Disclosure Recognised by the HKQAA Hong Kong Green and Sustainability Contribution Awards 2025

HONG KONG, May 13, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) was the proud recipient of the Outstanding Award for ESG Disclosure Contribution for its commendable progress in ESG (environment, social and governance)...

NSF-Certified: Vital Premium Water Raises the Bar for Quality and Trust in Cambodia

NSF-Certified: Vital Premium Water Raises the Bar for Quality and Trust in Cambodia

PHNOM PENH, Cambodia, May 12, 2025 /PRNewswire/ -- In a historic milestone for Cambodia's beverage industry, Vital Premium Water proudly announced today that it has officially received the NSF Beverage Quality Certification, making it the first...

CIMC Modular Building Systems Triumphs with Dual International Awards at 2025 World of Modular Conference

CIMC Modular Building Systems Triumphs with Dual International Awards at 2025 World of Modular Conference

SHENZHEN, China, May 7, 2025 /PRNewswire/ -- CIMC Modular Building Systems (CIMC MBS), a global leader in advanced modular construction, has earned two prestigious awards at the 2025 World of Modular Conference, organized by the Modular Building...

The products of Tianneng have received widespread attention

The products of Tianneng have received widespread attention

JAKARTA, Indonesia, May 5, 2025 /PRNewswire/ -- Since entering the Indonesian market in 2023, Tianneng has continued to promote its localization strategy in Southeast Asia. In 2024, the company set up an office in Indonesia to build a local support...

IND Application for NTS071, Nutshell Therapeutics' p53 Y220C Allosteric Reactivator, Received US FDA clearance

IND Application for NTS071, Nutshell Therapeutics' p53 Y220C Allosteric Reactivator, Received US FDA clearance

SHANGHAI, May 4, 2025 /PRNewswire/ -- On April 23, 2025, Nutshell Therapeutics ( Shanghai ) Co., LTD. received IND clearance from the FDA to initiate P hase 1 clinical trial in the United States for its NTS071, a novel small molecule allosteric...

The flagship model made a stunning debut, and the smart factory received widespread praise: Aima Technology showcased the "Made in China" hardcore strength at the Canton Fair

The flagship model made a stunning debut, and the smart factory received widespread praise: Aima Technology showcased the "Made in China" hardcore strength at the Canton Fair

TIANJIN, China, April 30, 2025 /PRNewswire/ -- From April 15 to 19, the 137th China Import and Export Fair (Canton Fair) was held in Guangzhou. As a leading electric two-wheeler company, Aima Technology of China showcased its flagship product, the...

Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE

Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE

HEFEI, China, April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved Phase IIb clinical trial of KPG-818...

Malaysia Aviation Group Achieves Positive NIAT of RM54mil and Third Consecutive Operating Profit on the Back of Operational Headwinds

Malaysia Aviation Group Achieves Positive NIAT of RM54mil and Third Consecutive Operating Profit on the Back of Operational Headwinds

Positive EBITDA at RM788mil with Operating Profit at RM113mil Stronger load factor, averaging 80%, a 3-percentage point increase from 2023 KUALA LUMPUR, Malaysia, April 24, 2025 /PRNewswire/ -- Malaysia Aviation Group ("MAG" or "the Group") reports...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu